New York, NYCIK 15690644 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
90 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Arcutis Biotherapeutics Inc | 11.96M | $347.43M | 8.7% | +1.49M | Added |
| 2 | Benitec Biopharma Inc | 11.55M | $155.56M | 3.9% | +1.67M | Added |
| 3 | Legend Biotech Corp | 6.61M | $143.67M | 3.6% | +2.79M | Added |
| 4 | Eyepoint Pharmaceuticals Inc |
| 7.83M |
| $143.01M |
| 3.6% |
| +1.63M |
| Added |
| 5 | Arcus Biosciences Inc | 5.19M | $123.65M | 3.1% | +1.50M | Added |
| 6 | Immatics N.V | 11.19M | $117.50M | 2.9% | −840.0K | Reduced |
| 7 | Biohaven Ltd | 10.29M | $116.14M | 2.9% | +4.67M | Added |
| 8 | Meta Platforms Inc | 169.1K | $111.60M | 2.8% | −1.9K | Reduced |
| 9 | Apellis Pharmaceuticals Inc | 4.14M | $103.98M | 2.6% | +1.26M | Added |
| 10 | Nvidia Corporation | 530.9K | $99.01M | 2.5% | +47.4K | Added |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio